Adenosine vs Diltiazem for Treatment of SVT in the ED
Recruiting
This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
08/01/2025
Locations: University of Iowa Health Care, Iowa City, Iowa
Conditions: Supraventricular Tachycardia (SVT)
RLE Outcomes With Bilateral Implantation of Odyssey IOLs
Recruiting
This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
08/01/2025
Locations: Mann Eye Institute, Houston, Texas
Conditions: Refractive Lens Exchange
A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use
Recruiting
The goal of this clinical trial is to compare buprenorphine formulations (sublingual buprenorphine versus long-acting injectable buprenorphine) for treating opioid use disorder among individuals who use fentanyl and/or other high potency synthetic opioids. Individuals aged 18-65 will be eligible for enrollment. The main questions it aims to answer are: Are there differences in frequency of drug use after individuals start treatment with sublingual buprenorphine compared to injectable buprenorph... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
08/01/2025
Locations: Substance Treatment and Research Service, New York, New York
Conditions: Opioid Use Disorder
Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Recruiting
The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT. This study will collect data in an observational disease registry involving no intervention to the participants and will not influence standard medical care or impact treatment decisions for participants.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: Synexus Clinical Research, US INC, Wilmington, North Carolina
Conditions: Tenosynovial Giant Cell Tumor
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Recruiting
The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with ASCVD who have elevated lipoprotein(a) (Lp(a)), and who are on background inclisiran treatment for elevated low-density lipoprotein cholesterol (LDL-C).
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
08/01/2025
Locations: National Heart Institute, Beverly Hills, California +17 locations
Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)
A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression
Recruiting
This study will adapt and assess the preliminary effectiveness of a community health worker-delivered mental health counselling intervention delivered remotely to reduce anxiety and depression among people with HIV in Florida.
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
08/01/2025
Locations: University of Florida, Gainesville, Florida
Conditions: HIV, Depression, Anxiety
Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke
Recruiting
Our proposed study, "NEUROBALANCE Stroke,"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants who have had a stroke at least 6 months before enrolment and experience persistent balance and gait deficits. Participants will be randomized into three groups: (1) robotic balance training with acti... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/01/2025
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Stroke, Stroke (CVA) or Transient Ischemic Attack, Stroke Ischemic, Stroke Gait Rehabilitation, Balance Deficits
Development of the Couplet Care Bassinet
Recruiting
The goal of this study is to evaluate the impact of the Couplet Care bassinet on maternal-infant outcomes in the postnatal hospital setting. The main question this study aims to answer is: Does the Couplet Care bassinet have better maternal-infant outcomes compared to the standard bassinet? The mother participants will: -be surveyed about experiences with and use of the bassinet including: the mother's sleep, breastfeeding, calls to staff, infant location, and satisfaction. Charts will be re... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: Johns Hopkins Hospital, Baltimore, Maryland
Conditions: Breastfeeding, Sleep, Patient Satisfaction
Investigations of Reproductive Cancers in Women
Recruiting
The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.
Gender:
FEMALE
Ages:
Between 45 years and 100 years
Trial Updated:
08/01/2025
Locations: University of Alabama, Birmingham, Birmingham, Alabama +14 locations
Conditions: Uterine Cancer
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
Recruiting
The goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard AF treatments.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
08/01/2025
Locations: The University of Arizona College of Medicine- Phoenix, Phoenix, Arizona +1 locations
Conditions: Overweight or Obesity, Atrial Fibrillation
Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial
Recruiting
This phase I/II trial examines if buffered lidocaine reduces the pain that patients may experience during prostate biopsy. Prostate biopsies are typically performed awake, in the office, with only local anesthetic. As a result, many patients note considerable pain during these procedures. Local anesthetics such as lidocaine are typically acidic, which is thought to cause pain and burning during infiltration (injection). As a result, buffered local anesthetic has become the standard of care (SOC)... Read More
Gender:
MALE
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
Conditions: Prostate Cancer
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
Recruiting
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Gender:
ALL
Ages:
50 years and above
Trial Updated:
08/01/2025
Locations: Associated Retina Consultans, Gilbert, Arizona +154 locations
Conditions: Wet Age Related Macular Degeneration, wAMD